Review : Heparin-induced osteoporosis in pregnancy

Greer IA , de Swiet M. Thrombosis prophylaxis in obstetrics and gynaecology. Br J Obstet Gynaecol 1993; 100: 37-40.

Nelson-Piercy C. Hazards of heparin: Bleeding, allergy, heparin-induced thrombocytopenia, osteoporosis . In: Greer I (ed). Thromboembolic Disease in Obstetrics and Gynaecology. Bailliere's Clinical Obstetrics & Gynaecology, 1997, in press.

Dahlman TC Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin . Am J Obstet Gynecol 1993; 168: 1265-1270.

Smith R. , Athanasou NA , Ostlere SJ , Vipond SE Pregnancy-associated osteoporosis. Q J Med 1995; 88: 865-878.

Yamamoto N. et al. Bone mineral density and bone histomorphometric assessment of postpregnancy osteoporosis: a report of five patients. Calcif Tissue Int 1994; 54: 20-25.

Sowers M. et al. A prospective evaluation of bone mineral change in pregnancy . Obstetrics and Gynecology 1991; 77: 841-845.

Khastgir G. et al. Changes in bone density and biochemical markers of bone turnover in pregnancy associated osteoporosis. Br J Obstet Gynaecol 1996; 103: 716-718.

Aarskog D. , Aksnes L. , Lehmann V. Low 1,25-dihydroxy vitamin D in heparin induced osteopenia. Lancet 1980; ii: 650-651.

Avioli LV Heparin-induced osteopenia: An appraisal. Adv Exp Med Biol 1975; 52: 375-387.

Matzsch T. et al. Heparin-induced osteoporosis in rats. Thrombosis and Haemostasis 1986; 56: 293-294.

Fuller K. , Chambers TJ , Gallagher AC Heparin augments osteoclast resorption-stimulating activity in serum. J Cell Physiol 1991; 147: 208-214.

Simmons HA , Raisz LG Effects of acid and basic fibroblast growth factor and heparin on resorption of cultured fetal rat long bones. J Bone Mineral Research 1991; 6: 1301-1305.

Shaughnessy SG , Young E. , Deschamps P. , Hirsch J. The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria. Blood 1995; 86: 1368-1373.

Hurley MM , Kream BE , Raisz LG Structural determinants of the capacity of heparin to inhibit collagen synthesis in 21-day fetal rat calvariae. J Bone Mineral Research 1990; 5: 1127-1133.

Dahlman T. , Sjoberg HE , Hellgren M. , Bucht E. Calcium homeostasis in pregnancy during long-term heparin treatment. Br J Obstet Gynaecol 1992; 99: 412-416.

Zimran A. , Shilo S. , Fisher D. , Bab I. Histomorphometric evaluation of reversible heparin-induced osteoporosis in pregnancy. Archives of Internal Medicine 1986 ; 146: 386-388.

Griffiths HT , Liu DT Severe heparin osteoporosis in pregnancy. Postgrad Med J 1984; 60: 424-425.

de Swiet M. Thromboembolism. In: de Swiet M (ed). Medical Disorders in Obstetric Practice. 3rd edn. Blackwell Science: Oxford , 1995.

Howell R. , Fidler J. , Letsky EA , de Swiet M. The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial . Br J Obstet Gynaecol 1983; 90: 1124-1128.

Dahlman T. , Lindvall N. , Hellgren M. Osteopenia in pregnancy during long-term heparin treatment: a radiological study post partum. Br J Obstet Gynaecol 1990 ; 97: 221-228.

de Swiet M. et al. Prolonged heparin therapy in pregnancy causes bone demineralisation (heparin-induced osteopenia). Br J Obstet Gynaecol 1983; 90: 1129-1134.

Dahlman T. , Sjoberg HE , Ringertz H. Bone mineral density during long-term prophylaxis with heparin in pregnancy . Am J Obstet Gynecol 1994; 170: 1315.

Barbour LA et al. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gyn 1994 ; 170: 862-869.

Haram K. , Thordarson H. , Hervig T. Calcium homeostasis in pregnancy and lactation. Acta Obstet Gynecol Scand 1993; 72: 509-513.

Nelson-Piercy C. Low molecular weight heparin for obstetric thromboprophylaxis. Br J Obstet Gynaecol 1994 ; 101: 6-8.

Warkentin TE et al. Heparin-induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-1335.

Monreal M. et al. Heparin-related osteoporosis in rats. A comparative study between unfractionated heparin and a low molecular weight heparin. Haemostasis 1990; 20: 204-207.

Matzsch T. et al. Effects of low molecular weight heparin and unfragmented heparin on induction of osteoporosis in rats. Thrombosis Haemostasis 1990; 63: 505-509.

Murray WJ , Lindo VS , Kakkar VV , Melissari E. Long-term administration of heparin and heparin fractions and osteoporosis in experimental animals. Blood Coagulation and Fibrinolysis 1995; 6: 113-118.

Monreal M. et al. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thrombosis Haemostasis 1994; 71: 7-11.

Melissari E. et al. Use of low molecular weight heparin in pregnancy. Thrombosis Haemostasis 1992; 68: 652-656.

Hunt BJ et al. Low molecular weight heparin (Fragmin) during pregnancy. Thrombosis Haemostasis 1997; 77: 39-43.

Nelson-Piercy C. , Letsky EA , de Swiet M. Low Molecular Weight Heparin for Obstetric Thromboprophylaxis: experience of 69 pregnancies in 61 high risk women. Am J Obstet Gynecol 1997; 176: 1062-1068

Shefras J. , Farquharson RG Bone density studies in pregnant women receiving heparin. Eur J Obstet Gynecol Reprod Biol 1996; 65: 171-174.

Kutteh WH Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174: 1584-1589.

Rai R. , Cohen H. , Dave M. , Regan L. Randomized trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997; 314: 253-257.

Department of Health, Welsh Office , Scottish Home and Health Department and Department of Health and Social Services, Northern Ireland: Confidential Enquiries into Maternal Deaths in the United Kingdom 1991-93. HMSO: London, 1996.